Announcements Trials
Browse Landscape

Phase

Phase NA 86Phase 2 77Phase 1 43Phase 1/2 33Phase EARLY_PHASE1 13Phase 3 9Phase 2/3 5Phase 4 3

Status

Recruiting 170Active not recruiting 76Not yet recruiting 54Completed 38Terminated 16Withdrawn 5Suspended 5Enrolling by invitation 3

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Oligodendroglioma 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Carcinoma, Renal Cell 1Astrocytoma 1

Interventions

vocimagene amiretrorepvec 1pembrolizumab 1Temozolomide 1Radiotherapy 1Radiation 1DNA 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Withdrawn × 1 year × Clear all
NCT04105374 2026-05-07

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

NRG Oncology

Phase 2/3 Withdrawn
CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT06866951 2025-12-16

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

Women's Hospital School Of Medicine Zhejiang University

Phase 2/3 Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT07084909 2025-12-10

HARRIER

Lantheus Medical Imaging

Phase 2/3 Withdrawn
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01861938 2025-10-02

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Hadassah Medical Organization

Phase 2/3 Withdrawn
Dermatologic

Melanoma, Neoplasm Metastasis

NCT06513884 2025-06-22

A Study of HB-202/HB-201 With Pembrolizumab in Patients With HPV16+ Recurrent/Metastatic Oropharyngeal Cancer

Hookipa Biotech GmbH

Phase 2/3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡